Cytokinetics (CYTK)
(Delayed Data from NSDQ)
$65.27 USD
-0.01 (-0.02%)
Updated May 8, 2024 04:00 PM ET
After-Market: $65.30 +0.03 (0.05%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: AMC |
3/2024 | $-1.16 | -17.44% |
Earnings Summary
For their last quarter, Cytokinetics (CYTK) reported earnings of -$1.33 per share, missing the Zacks Consensus Estimate of -$1.16 per share. This reflects a negative earnings surprise of 14.66%. Look out for CYTK's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$1.16 per share, reflecting a year-over-year increase of 15.94%.
Earnings History
Price & Consensus
Zacks News for CYTK
Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Tops Revenue Estimates
CYTK: What are Zacks experts saying now?
Zacks Private Portfolio Services